Jürgen Kuball
Utrecht haematologist and immunotherapy researcher on the daily board of UMC Utrecht's cancer programme, known for gamma-delta T cell receptor-engineered cell therapies.
Overview
Jürgen Kuball is Professor of Haematology at UMC Utrecht and a member of the Daily Board of its Strategic Program Cancer. He leads the haematology department and a translational research group developing gamma-delta T cell receptor-based cellular immunotherapies for haematological and solid cancers. His work spans allogeneic stem cell transplantation and engineered T cell products.
Pages like this
not linked directly; found by shared links- PersonNicolaas P.M. Schaap
Shares Multiple myeloma, Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.
- PersonMartin Bornhäuser
Shares Multiple myeloma, Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.
- PersonWouter de Laat
Shares UMC Utrecht Cancer Center and the tag leadership.
- PersonNorbert Vey
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.
- PersonAkifumi Takaori
Shares Multiple myeloma, Acute myeloid leukaemia and the tags leadership, clinician-scientist.
- PersonBrian Huntly
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.
- PersonKonstanze Döhner
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.
- PersonChristian Brandts
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.